Bayer Investor Relations

Bayer is committed to providing sustainable solutions that address humanity’s most fundamental needs for essential healthcare and nutritious food. The Bayer Investor Relations Team is dedicated to creating transparency, fostering dialogue, and delivering value to our stakeholders. 

Business colleagues sitting at a bright conference table during a meeting.
Four professionals gather around a laptop at a conference table in an office at night. A man leans over the screen, another sits looking thoughtfully, a woman takes notes, and a woman wearing a black turban gestures while looking at the display.

Our Q1 Statement

Bayer reports solid start to the year and confirms currency-adjusted Group guidance for 2026.

Quarterly Statements 

A double exposure image overlaying a close-up of hands holding a smartphone with a bright, glass-facade modern office building.

Bayer publishes quarterly statements for the first and third quarter and half-year reports, including key financial figures.

Annual Reports

Close-up of a person's hands holding a digital tablet outdoors, with a finger touching the glossy screen reflecting light and shadows.

The integrated Annual Report combines our financial reporting and our nonfinancial statement.

businesswoman_in_train.jpeg

Investor News

Read the latest press releases, investor updates, and important announcements from our company here.

Aerial bird's-eye view of the curved Bayer headquarters building. In the center of the green, landscaped courtyard, a large circular pavement feature prominently displays the iconic Bayer cross logo.

Why Invest in Bayer?

The investment case provides a concise overview of the core business areas - Crop Science, Pharmaceuticals and Consumer Health - as well as current key metrics, innovation pipelines, and market opportunities for the year 2026.